Allium Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Buy
1,196
+9
+0.8% +$9.12K 0.88% 21
2025
Q4
$1.28M Hold
1,187
1.01% 20
2025
Q3
$906K Sell
1,187
-174
-13% -$129K 0.75% 26
2025
Q2
$1.06M Buy
1,361
+1
+0.1% +$777 0.92% 21
2025
Q1
$1.12M Buy
+1,360
New +$1.13M 1.02% 18

Other funds holding LLY

Allium Financial Advisors's LLY Position: Q1 2026 in Review

Allium Financial Advisors increased its Eli Lilly (LLY) stake by 0.76% in Q1 2026, buying an estimated $9.12K and bringing the position to 1,196 shares worth $1.1M. The position accounts for 0.88% of the portfolio, ranked #21.

Allium Financial Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.28M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Allium Financial Advisors held 1,196 shares of Eli Lilly worth $1.1M as of Q1 2026.
  • Allium Financial Advisors bought 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
  • Eli Lilly made up 0.88% of Allium Financial Advisors's portfolio in Q1 2026, its #21 holding.
  • Allium Financial Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Allium Financial Advisors's Eli Lilly position peaked at $1.28M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Allium Financial Advisors's 13F filing for Q1 2026, filed 7 May 2026.